Joseph J. Drabick

5.7k total citations · 2 hit papers
154 papers, 4.1k citations indexed

About

Joseph J. Drabick is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Joseph J. Drabick has authored 154 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Oncology, 33 papers in Molecular Biology and 30 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Joseph J. Drabick's work include Cancer Immunotherapy and Biomarkers (36 papers), Bladder and Urothelial Cancer Treatments (22 papers) and Immunotherapy and Immune Responses (14 papers). Joseph J. Drabick is often cited by papers focused on Cancer Immunotherapy and Biomarkers (36 papers), Bladder and Urothelial Cancer Treatments (22 papers) and Immunotherapy and Immune Responses (14 papers). Joseph J. Drabick collaborates with scholars based in United States, India and China. Joseph J. Drabick's co-authors include Jill Glasspool‐Malone, Robert W. Malone, Stella Somiari, Ming Yin, Cristina I. Truica, Wafik S. El‐Deiry, Lanlan Zhou, Peng Li, Po‐Hsun Huang and Zhangming Mao and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and JAMA.

In The Last Decade

Joseph J. Drabick

149 papers receiving 4.0k citations

Hit Papers

Acoustic separation of ci... 2015 2026 2018 2022 2015 2016 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joseph J. Drabick United States 29 1.3k 1.0k 830 778 641 154 4.1k
Sharon S. Evans United States 35 1.5k 1.2× 1.4k 1.4× 2.4k 2.8× 950 1.2× 217 0.3× 68 5.3k
Robert V. Rouse United States 48 1.6k 1.2× 1.3k 1.2× 1.9k 2.3× 729 0.9× 1.3k 2.0× 129 7.3k
Walter A. Hall United States 45 1.4k 1.1× 828 0.8× 850 1.0× 695 0.9× 1.2k 1.8× 216 7.9k
Dominique Bellet France 32 1.1k 0.9× 1.2k 1.1× 1.4k 1.7× 519 0.7× 293 0.5× 70 4.2k
Jeffrey M. Beekman Netherlands 34 1.0k 0.8× 2.6k 2.5× 626 0.8× 930 1.2× 473 0.7× 114 6.0k
Toshiaki Kikuchi Japan 36 1.5k 1.2× 1.1k 1.0× 1.3k 1.5× 161 0.2× 471 0.7× 293 4.9k
Thomas F. Warner United States 40 881 0.7× 1.1k 1.0× 561 0.7× 511 0.7× 878 1.4× 134 5.1k
José Moreno Mexico 30 878 0.7× 840 0.8× 752 0.9× 199 0.3× 290 0.5× 90 2.9k
Giovanna Schiavoni Italy 34 1.8k 1.4× 908 0.9× 3.5k 4.2× 474 0.6× 414 0.6× 73 5.6k
Chamindie Punyadeera Australia 42 1.0k 0.8× 2.0k 1.9× 530 0.6× 949 1.2× 350 0.5× 165 5.3k

Countries citing papers authored by Joseph J. Drabick

Since Specialization
Citations

This map shows the geographic impact of Joseph J. Drabick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph J. Drabick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph J. Drabick more than expected).

Fields of papers citing papers by Joseph J. Drabick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph J. Drabick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph J. Drabick. The network helps show where Joseph J. Drabick may publish in the future.

Co-authorship network of co-authors of Joseph J. Drabick

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph J. Drabick. A scholar is included among the top collaborators of Joseph J. Drabick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph J. Drabick. Joseph J. Drabick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhu, Junjia, Ahmad Ozair, Jeffrey Sivik, et al.. (2025). A Population-Level Real-World Analysis and Single-Center Validation of Melanoma Brain Metastasis Epidemiology following Dual-Agent Immunotherapy. Clinical Cancer Research. 31(15). 3276–3284.
3.
Tchelebi, Leila T., Ming Wang, Eric J. Lehrer, et al.. (2021). Radiotherapy and Receptor Tyrosine Kinase Inhibition for Solid Cancers (ROCKIT): A Meta-Analysis of 13 Studies. JNCI Cancer Spectrum. 5(4). 15 indexed citations
4.
Gandhi, Shipra, Manu Pandey, Kristopher Attwood, et al.. (2020). Phase I Clinical Trial of Combination Propranolol and Pembrolizumab in Locally Advanced and Metastatic Melanoma: Safety, Tolerability, and Preliminary Evidence of Antitumor Activity. Clinical Cancer Research. 27(1). 87–95. 87 indexed citations
5.
Jia, Bei, Kevin Rakszawski, David F. Claxton, et al.. (2019). Eomes+T-betlow CD8+ T Cells Are Functionally Impaired and Are Associated with Poor Clinical Outcome in Patients with Acute Myeloid Leukemia. Cancer Research. 79(7). 1635–1645. 48 indexed citations
6.
Rao, Pooja, Joel E. Segel, Lisa M. McGregor, et al.. (2019). Attendance at National Cancer Institute and Children's Oncology Group Facilities for Children, Adolescents, and Young Adults with Cancer in Pennsylvania: A Population-Based Study. Journal of Adolescent and Young Adult Oncology. 9(1). 47–54. 3 indexed citations
7.
Hollenbeak, Christopher S., Matthew D. Taylor, Monali Vasekar, et al.. (2019). Postoperative chemotherapy and radiation improve survival following cardiac sarcoma resection. Journal of Thoracic and Cardiovascular Surgery. 161(1). 110–119.e4. 19 indexed citations
8.
Zaorsky, Nicholas G., Djibril M. Ba, Joel E. Segel, et al.. (2019). The cost of prostate cancer care to society and to patients in the United States.. Journal of Clinical Oncology. 37(7_suppl). 116–116. 7 indexed citations
9.
Ribas, Antoni, Theresa Medina, Shivaani Kummar, et al.. (2018). SD-101 in Combination with Pembrolizumab in Advanced Melanoma: Results of a Phase Ib, Multicenter Study. Cancer Discovery. 8(10). 1250–1257. 237 indexed citations
10.
Yin, Ming, et al.. (2017). Prognosis and treatment of non-metastatic primary and secondary breast angiosarcoma: a comparative study. BMC Cancer. 17(1). 295–295. 62 indexed citations
11.
Kuzu, Omer F., Raghavendra Gowda, Arati Sharma, et al.. (2017). Identification of WEE1 as a target to make AKT inhibition more effective in melanoma. Cancer Biology & Therapy. 19(1). 53–62. 18 indexed citations
12.
Kuzu, Omer F., Raghavendra Gowda, Arati Sharma, et al.. (2017). Improving pharmacological targeting of AKT in melanoma. Cancer Letters. 404. 29–36. 10 indexed citations
13.
Yin, Ming, Monika Joshi, Richard P. Meijer, et al.. (2016). Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: A Systematic Review and Two-Step Meta-Analysis. The Oncologist. 21(6). 708–715. 314 indexed citations breakdown →
14.
Yin, Ming, Wenge Wang, Jennifer Rosenberg, et al.. (2015). Targeted Therapy in Collecting Duct Carcinoma of the Kidney: A Case Report and Literature Review. Clinical Genitourinary Cancer. 14(2). e203–e206. 11 indexed citations
15.
Drabick, Joseph J., Giampaolo Talamo, Jeffrey G. Supko, et al.. (2013). A phase II pilot efficacy trial of the combination regimen peg asparaginase/peg liposomal doxorubicin/dexamethasone (ODD) in patients with refractory lymphoid malignancies (NCT00837200).. Journal of Clinical Oncology. 31(15_suppl). e19502–e19502. 1 indexed citations
16.
Glasspool‐Malone, Jill, Stella Somiari, Joseph J. Drabick, & Robert W. Malone. (2000). Efficient Nonviral Cutaneous Transfection. Molecular Therapy. 2(2). 140–146. 94 indexed citations
17.
Gambel, Jeffrey M., Joseph J. Drabick, J Seriwatana, & Bruce L. Innis. (1997). Seroprevalence of hepatitis E virus (HEV) among united nations mission in haiti (UNMIH) peacekeepers, 1995. Clinical Infectious Diseases. 25(2). 1 indexed citations
18.
Drabick, Joseph J., et al.. (1997). Analysis of active live immunization versus passive humoral immunotherapy against attenuated and virulent strains of Francisella tularensis. 6(2). 67–74. 1 indexed citations
20.
Drabick, Joseph J., et al.. (1992). CD4 Lymphocyte Decline and Survival in Human Immunodeficiency Virus Infection. AIDS Research and Human Retroviruses. 8(12). 2039–2047. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026